文献速递妇科产科

绝经后良性子宫切除术中卵巢切除的健康结局:一项基于人群的研究

Health outcomes following oophorectomy during benign hysterectomy in those who are in postmenopausal ages: a population-based study.
PubMed 文献 · Am J Obstet Gynecol · 2026-04-10

该回顾性人群研究利用加拿大不列颠哥伦比亚省1996至2019年关联行政数据,评估50-60岁女性良性子宫切除术时行双侧输卵管卵巢切除术对心血管和骨骼健康的影响。中位随访至2020年,结果显示卵巢切除组心血管复合事件和骨骼结局无显著差异,但心血管疾病易感疾病(如糖尿病和高血压)诊断风险及心血管药物处方风险更高,且术后启动激素治疗的可能性显著增加。

要点

  • 绝经后子宫切除术中行双侧卵巢切除不增加心血管复合事件和骨质疏松/骨折风险。
  • 但卵巢切除组心血管易感疾病(糖尿病、高血压)诊断风险升高(aHR 1.16)。
  • 卵巢切除组术后启动激素治疗的可能性更高(aHR 2.04)。

核心结论

  • 绝经后良性子宫切除术中切除卵巢未增加不良心血管或骨骼健康结局风险,但可能与心血管疾病易感疾病诊断风险及相应药物处方风险增加相关,提示保留绝经后卵巢可能有益。

研究设计与样本

  • 纳入18,676例50-60岁行良性子宫切除术的患者,其中46.3%(n=8653)同时行双侧输卵管卵巢切除术。
  • 采用多变量Cox比例风险模型,调整手术年龄、手术年份、术后系统性绝经激素治疗使用、基线心血管或骨骼健康状况、手术指征和手术路径。

主要发现

  • 心血管复合事件结局(充血性心力衰竭、心肌梗死、脑血管疾病和缺血性心脏病)和心血管操作结局(经皮冠状动脉介入、冠状动脉旁路移植或心导管检查)在组间无统计学显著差异。
  • 卵巢切除组心血管疾病易感疾病(如糖尿病和高血压)诊断风险更高(调整后风险比1.16;95%置信区间1.08-1.25),心血管药物处方风险也更高(调整后风险比1.07;95%置信区间1.00-1.15)。
  • 骨质疏松、骨折或启动骨质疏松药物治疗在调整协变量后组间无显著差异。
  • 卵巢切除组术后启动绝经激素治疗的可能性显著高于卵巢保留组(调整后风险比2.04;95%置信区间1.92-2.17)。
  • 亚组分析结果基本一致,尤其在50-55岁参与者中。

临床怎么用

  • 对于50-60岁绝经后女性行良性子宫切除术,可考虑保留卵巢以降低心血管易感疾病诊断和药物治疗风险。
  • 术后应关注卵巢切除患者的心血管疾病易感疾病(如糖尿病、高血压)筛查及激素治疗需求。

局限性

  • 回顾性观察性设计,可能存在残余混杂。
  • 使用行政数据,可能存在编码不准确或未测量的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While postmenopausal bilateral salpingo-oophorectomy during benign hysterectomy may reduce the likelihood of adnexal surgeries and the risk of ovarian cancer, more evidence is needed to evaluate the health impacts of this procedure. Given the role of residual hormone secretion by postmenopausal ovaries, we hypothesize that performing bilateral oophorectomy at the time of benign hysterectomy among postmenopausal people may impact the risk of cardiovascular diseases and accelerated bone loss, both of which can significantly affect the quality of life in aging women. OBJECTIVE: To evaluate cardiovascular and bone health outcomes in people aged 50 to 60 years who did and did not undergo bilateral salpingo-oophorectomy at the time of hysterectomy. STUDY DESIGN: Retrospective population-based study using linked administrative data from British Columbia, Canada between Janaury 1, 1996 and September 30, 2019 with follow-up until December 31st, 2020. Multivariate Cox Proportional hazards models were used, adjusting for age at surgery, year of surgery, systemic menopausal hormone therapy use after surgery, and presence of baseline cardiovascular or bone health conditions up to 5 years before surgery, indication, and route of surgery. Subgroup analyses were conducted by stratifying individuals into early postmenopausal ages (50-55 years) and later postmenopausal ages (56-60 years). Statistical analyses were performed in R software version 4.0.3, STATA 16.1 (StataCorp) and SAS 9.4 (SAS Institute, Cary, NC) software. RESULTS: Of the 18,676 patients who remained in the study after applying exclusion criteria, 46.3% (n=8653) had hysterectomy with bilateral salpingo-oophorectomy. We observed no statistically significant difference in cardiovascular composite event outcomes (congestive heart failure, myocardial infarction, cerebral vascular disease, and ischemic heart disease) and cardiovascular procedure outcomes (percutaneous coronary intervention, coronary artery bypass, or cardiac catheterization) across the groups. Nevertheless, patients who had concurrent oophorectomy were at a higher risk of being diagnosed with conditions that predispose them to cardiovascular diseases, such as diabetes and hypertension (adjusted hazard ratio, 1.16; 95% confidence interval, 1.08-1.25), and were also more likely to be prescribed cardiovascular medications (adjusted hazard ratio, 1.07; 95% confidence interval, 1.00-1.15). No significant differences were observed between the groups in terms of osteoporosis, fractures, or initiating osteoporosis medication after adjustment for covariates. The likelihood of starting menopausal hormone therapy after surgery was significantly higher for those who had hysterectomy with bilateral oophorectomy compared to hysterectomy with ovarian conservation (adjusted hazard ratio, 2.04; 95% confidence interval, 1.92-2.17). Results mostly remained consistent in the subgroup analyses, especially among participants aged 50 to 55 years. CONCLUSION: Our study revealed that although removing postmenopausal ovaries at the time of benign hysterectomy is not associated with an increased risk of adverse cardiovascular or bone health-related outcomes, it might be associated with an increased risk of cardiovascular disease predisposing conditions and the need for prescribing medications for those conditions and hormone therapy. This could indicate a benefit for retaining postmenopausal ovaries at the time of benign hysterectomy among postmenopausal patients. Given the existing variation in practice, pragmatic trials are recommended to inform the decisions on performing oophorectomy in an average-risk population.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Abreu do Valle H, Salmanpour A, Kaur P, et al. Health outcomes following oophorectomy during benign hysterectomy in those who are in postmenopausal ages: a population-based study. Am J Obstet Gynecol. 2026. PMID: 41967739. doi:10.1016/j.ajog.2026.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。